Previous Article | Next Article ![]()
Journal of Bacteriology, December 2006, p. 8335-8342, Vol. 188, No. 24
0021-9193/06/$08.00+0 doi:10.1128/JB.01318-06
Partha Mukhopadhyay,
Matthew J. Wood,
F. Wayne Outten,||
Jason A. Opdyke, and
Gisela Storz*
Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
Received 18 August 2006/ Accepted 14 September 2006
|
|
|---|
|
|
|---|
OxyR is a member of the LysR family of transcriptional regulators. This family comprises the most abundant class of transcriptional regulators in bacterial cells (12). Most of the LysR-type regulators are between 30 and 35 kDa in molecular size and form homodimers or homotetramers. The proteins have a very conserved amino-terminal domain containing a helix-turn-helix DNA-binding motif. Unlike OxyR, most of the LysR family members are activated by binding to effector molecules. However, for all of the LysR-type transcriptional regulators, the carboxy-terminal part of the protein constitutes the inducer-binding or regulatory domain.
OxyR, like most of the LysR family members, binds overlapping or adjacent to the promoter to repress or activate transcription (reviewed in reference 16). Footprinting experiments showed oxidized OxyR increases RNA polymerase binding to the OxyR-dependent promoters, suggesting that OxyR activates transcription by recruiting RNA polymerase (8). This interaction may be due to direct contacts between the
subunit of RNA polymerase (encoded by rpoA) and OxyR, since strains expressing
mutants lacking the carboxy-terminal domain (
-CTD) are unresponsive to OxyR activation (22). A screen for rpoA mutations that resulted in decreased OxyR activation of the katG target gene led to the isolation of 11
mutants with substitutions for amino acids 265, 268, 269, 293, 294, 298, 299, 300, and 307 in the
-CTD (23). However, it has not been established whether OxyR makes direct contacts with this domain of RNA polymerase. Since all of the mutations map to the
DNA-binding domain, the reduced activation observed may solely be due to reduced RNA polymerase binding to the katG, ahpC, and oxyS promoters rather than an OxyR contact site on the
-CTD. To gain insight into possible contacts between OxyR and RNA polymerase, we carried out alanine scanning and random mutagenesis of oxyR and screened for mutants unable to activate transcription.
|
|
|---|
and XL1-Blue were routinely used for plasmid preparation. GSO5 (8) was used for oxidant sensitivity test and for primer extension assays, TA4484 (24) was used for the overexpression and purification of mutant OxyR proteins, and GSO133 (25) was used for the oxyR-lacZ fusion assays. The
oxyR::Sp deletion was moved into GSO130 (25) by P1 transduction from N9716 (kindly provided by W. Gillette) to generate GSO131 (WX16). The
ahpCF::Kan deletion similarly was introduced into GSO131 by P1 transduction from FÅ369 (1) to construct GSO132 (WX21). P1 transductions were carried out as described previously (18). |
View this table: [in a new window] |
TABLE 1. E. coli strains used for this study
|
Mutagenesis.
The desired alanine substitutions were generated by using the QuikChange site-directed mutagenesis kit (Stratagene) and oligonucleotides carrying the appropriate codon substitutions. Two approaches were used to create the random mutations in the oxyR gene carried on pAQ5. First, pAQ5 was transformed into a mutator strain (XL1-Red). The plasmid isolated from about 500 transformants grown in LB medium with chloramphenicol for
24 h was then used to transform GSO132. As a second approach, chemical mutagenesis of pAQ5 was carried out as described previously (8). Briefly, 20 µl of pAQ5 plasmid DNA (5 µg) was mixed with 80 µl of 0.5 M potassium phosphate buffer (pH 6.0) containing 5 mM EDTA and 100 µl of 1 M hydroxylamine. The mixture was incubated at 65°C for 60 min. The DNA was dialyzed extensively with Tris-Cl-EDTA buffer and then used to transform XL1-Blue. The XL1-Blue transformants were collected, and plasmid DNA was again isolated and used to transform GSO132. For each mutant, the sequence of the entire oxyR gene was confirmed by sequencing.
Zone-of-inhibition assays. Aliquots (0.1 ml) of overnight cultures were mixed with 2.5 ml of top agar and plated on LB medium containing the appropriate selection. Disks impregnated with 10 µl of either 10% H2O2 or 4% cumene hydroperoxide were placed on the plates. The zones of inhibition surrounding the disks were measured after overnight incubation.
Primer extension assays. Cultures were grown to an optical density at 600 nm of 0.3 to 0.5 and split; half was left untreated, and the other half was exposed to 0.2 mM hydrogen peroxide. The cultures were shaken for 5 min, and the cells were collected. The total RNA was extracted by using TRIzol reagent (BRL). Primer extension assays were carried out with 5 µg of total RNA and an oligonucleotide (5'-GCAAAAGTTCACGTTGG) complementary to the oxyS gene that was labeled with T4 polynucleotide kinase. The probe was annealed to the RNA, and a 60-min extension reaction was carried out at 42°C using reverse transcriptase (Life Sciences Inc.). The products were analyzed by using an 8% sequencing gel.
Protein expression and purification. The wild-type and mutant OxyR proteins were overexpressed and purified as described previously (8). Briefly, TA4484 carrying the pGSO69 derivatives was grown to an optical density at 600 nm of 0.5, and expression was induced by 0.5 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) for 2 h. Cells were harvested and lysed by three passages through a French press. Cell debris was removed by centrifugation, and the OxyR protein in the supernatant was purified by passage over heparin-Sepharose and Mono-S columns (Pharmacia).
DNase I footprinting assays. DNase I footprinting assays were carried out as described previously (24). An end-labeled DNA fragment was incubated with 50 to 200 ng of purified protein in 25 µl of 0.5x TM buffer. The binding reaction mixtures were then treated with DNase I for 2 min, extracted with phenol-chloroform, and examined on 8% sequencing gels.
Immunoblotting.
-OxyR antiserum was generated by immunizing rabbits with purified OxyR protein (Covance). Total proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12% acrylamide and transferred to a nitrocellulose filter by electroblotting. The filter was probed with a 1:10,000 dilution of antiserum. Bound antibody was visualized by rabbit antiserum using the enhanced chemiluminescence Western blotting system from Amersham.
ß-Galactosidase assays. ß-Galactosidase assays were carried out according to the method of Miller (11).
|
|
|---|
![]() View larger version (82K): [in a new window] |
FIG. 1. Alignment of E. coli LysR family members. The amino acid sequences of the E. coli OxyR, CysB, IlvY, MetR, TdcA, and XapA LysR-type transcriptional regulators were aligned by using CLUSTAL W software. Numbering is based on the OxyR sequence. Amino acids identical in five of the six proteins are highlighted in black, and conserved residues are highlighted with gray. Brackets denote regions mutated in the alanine-scan mutagenesis. Positions of activation-defective mutations isolated in the random mutagenesis screen are indicated above the sequence.
|
|
View this table: [in a new window] |
TABLE 2. Peroxide sensitivity of alanine-scan mutants
|
![]() View larger version (41K): [in a new window] |
FIG. 2. Primer extension analysis of oxyS induction in alanine-scan mutants. Total RNA was isolated from the corresponding E. coli strains grown to mid-exponential phase and either left untreated () or exposed to 200 µM hydrogen peroxide (+) for 5 min. A labeled oligonucleotide capable of hybridizing to the OxyS RNA was incubated with 5 µg of each RNA sample and extended with reverse transcriptase.
|
![]() View larger version (47K): [in a new window] |
FIG. 3. DNase I footprint analysis of purified D142A and T238A OxyR mutant proteins binding to an oxyS-oxyR promoter fragment. The 100-bp EcoRI-HindIII fragment of pGSO40 (25) labeled at the HindIII site (top strand relative to the oxyS promoter) or EcoRI site (bottom strand relative to the oxyS promoter) was incubated with 50, 160, 170, and 150 ng of purified wild-type, C199S, T238A, and D142A OxyR, respectively. Footprinting assays were carried out in the absence of dithiothreitol; a short oxidized footprint is observed for wild-type OxyR under these conditions.
|
oxyR mutant strain, indicating a negatively charged residue is important in this position. The levels of the D142K mutant protein were elevated compared to the wild-type protein, although not to the extent observed for mutants carrying substitutions in the DNA-binding domain (see below). Thus, the D142K mutant may be somewhat defective in autorepression and DNA binding, and some of the lack of activation may be attributable to decreased promoter binding. However, the levels of the D142A, D142N, and D142Q mutants were similar to the wild-type levels, indicating that these activation-defective mutants are fully able to bind DNA. |
View this table: [in a new window] |
TABLE 3. Peroxide sensitivity of D142 mutants
|
![]() View larger version (35K): [in a new window] |
FIG. 4. (A) Immunoblot of D142 mutant protein levels. The total protein corresponding to equal numbers of cells was separated by SDS-PAGE, transferred to a nitrocellulose filter, and probed with -OxyR antiserum. (B) Primer extension analysis of oxyS induction in D142 mutants. The total RNA was isolated from the corresponding E. coli strains grown to mid-exponential phase and either left untreated () or exposed to 200 µM hydrogen peroxide (+) for 5 min. A labeled oligonucleotide capable of hybridizing to the OxyS RNA was incubated with 5 µg of each RNA sample and extended with reverse transcriptase.
|
(oxyS-lacZ)
oxyR::Sp
ahpCF::Kan strain (GSO132) carrying the pACYC184 control vector is white, whereas this strain carrying the pAQ5 plasmid encoding wild-type oxyR is red. On tetrazolium indicator plates, the GSO132/pACYC184 strain is red, and the GSO132/pAQ5 strain is white. pAQ5 was mutagenized by passage through a mutator strain or by treatment with hydroxylamine and transformed into GSO132. Plasmids were extracted from all white colonies identified on MacConkey plates and all red colonies identified on tetrazolium plates. The phenotypes were confirmed by reintroducing the plasmids into the same background. All of the mutants showing decreased oxyS-lacZ expression were tested for hydrogen peroxide sensitivity (Table 4). Immunoblots were also carried out to eliminate all mutants expressing truncated versions of OxyR (Fig. 5A and data not shown). The plasmids associated with hypersensitivity to hydrogen peroxide and expressing full-length OxyR were then sequenced. |
View this table: [in a new window] |
TABLE 4. Phenotype of uninducible mutants
|
![]() View larger version (36K): [in a new window] |
FIG. 5. (A) Immunoblot of OxyR protein levels in activation-defective mutants. Total protein corresponding to equal numbers of cells was separated by SDS-PAGE, transferred to a nitrocellulose filter, and probed with -OxyR antiserum. (B) Primer extension analysis of oxyS induction in activation-defective mutants. Total RNA was isolated from the corresponding E. coli strains grown to mid-exponential phase and either left untreated () or exposed to 200 µM hydrogen peroxide (+) for 5 min. A labeled oligonucleotide capable of hybridizing to the OxyS RNA was incubated with 5 µg of each RNA sample and extended with reverse transcriptase.
|
![]() View larger version (120K): [in a new window] |
FIG. 6. Positions of constitutive and activation-defective mutations on the OxyR structure. Space-filling model of the OxyR regulatory domain in the reduced (A) and oxidized (B) conformations was generated by using InsightII software (Accelrys Software, Inc.). The front view is given on the left, and the back view is on the right. One monomer is shown in aqua, and the second monomer is shown in green. The positions of the C199 and C208 residues are indicated in yellow. The residues affected by the constitutive mutations (T100, H114, H198, R201, and A233) isolated in a previous screen for elevated expression of an oxyS-galK fusion (8) are indicated in red. The residues found to be mutated in the activation-defective mutants (G96, G102, P103, H125, E126, T129, D142, F219, T238, and R273) described here are indicated in orange. The black box surrounds residues D142 and R273.
|
An additional six mutationsG96D, G102R, P103L, H125P, E126K, and F219Smapped to the interface between the two monomer subunits. Two of the corresponding mutants, P103L and G96D, had only minor defects in OxyS induction, and a third, H125P, was only partially defective (Fig. 5B). In contrast, no induction was detected for the G102R, E126K, and F219S mutants. Two of these stronger mutants, G102R and E126K, also had elevated OxyR levels (Fig. 5A) and increased oxyR-lacZ expression (Table 4), indicating that possible defects in oligomerization might be associated with defects in DNA binding. Interestingly, the G96D mutant had similar elevated levels of the OxyR protein and oxyR-lacZ expression but was far less defective in OxyS induction, raising the possibility that the G96D substitution actually enhances activation. Given the locations of the mutations, we suggest all six affect activation by altering the interaction between the monomers.
Four substitutionsT129A, D196G, C199Y, and T238Amapped at or near C199 and C208, the two redox-active cysteine residues. The C199Y mutation affects one of the two redox-active cysteines. The T129 residue touches C199, and the D196 residue is on the same loop as C199; it is likely that both of the corresponding mutations affect the reactivity of C199. The T238A mutation is equivalent to the mutation generated by the alanine-scan mutagenesis and is also thought to affect the reactivity of the redox-active cysteines. The T129, C199Y, and T238A mutant proteins had reduced footprints under oxidizing conditions (Fig. 2 and data not shown), a finding consistent with the suggestion that these mutants are impaired in disulfide bond formation. The T129A and T238A mutants are both hypersensitive to oxidants but still show some OxyS RNA induction. In contrast, the C199Y mutant is partially constitutively active, similar to what has been observed for a C208S mutant (9). The footprint of the D196G mutant protein was similar to the wild-type protein under oxidizing conditions. However, the mutation had minor effects; the D196G mutant was only partially sensitive to oxidants and only showed slightly reduced OxyS induction.
The remaining mutation, R273H, mapped to a surface-exposed residue and had a dramatic effect. Absolutely no OxyS induction was observed in this strain, indicating that the mutant is completely impaired in transcriptional activation. The R273H protein levels were somewhat elevated, though the expression of the oxyR-lacZ fusion was similar to the wild-type OxyR strain. We do not know the reason for the discrepancy between these two assays of autorepression, but the increased R273H levels may reflect a partial defect in DNA binding or altered sensitivity to degradation. Intriguingly, the R273H mutant was even more sensitive to both hydrogen peroxide and cumene hydroperoxide than the pACYC184 vector control strain, suggesting that expression of the mutant protein is somewhat detrimental to the cell.
D142 and R273 define a possible activating region. One mutant, D142A, isolated in our alanine-scan approach and another isolated in our random screen, R273H, show strong defects in OxyR activation of the oxyS target gene but only partial defects in DNA binding. Intriguingly, the two residues affected by the mutations are adjacent in the OxyR regulatory domain (Fig. 6). There are several possible explanations for the observed defect in transcription activation. D142A and R273H map to an interaction surface between the regulatory and DNA-binding domains of the structure of the full-length Ralstonia eutropha CbnR protein solved in the absence of inducer (14). Thus, the substitutions may be affecting transcription activation through some effects on DNA binding. The structure of a full-length LysR-type regulator in an inducer-bound, activated conformation is not yet available. However, given that R273 maps onto the surface of the CbnR structure and both D142 and R273 have the potential to be exposed in the activated conformation, the two residues may also correspond to a point of contact between OxyR and RNA polymerase and thus define an activating region on the OxyR protein. Alternatively, the D142A and R273H may be altering the OxyR conformation such that the actual contact residues can no longer interact with RNA polymerase.
Activating regions are well defined for a number of transcriptional regulators that are not members of the LysR family (reviewed in references 2 and 5). For example, the E34 and D38 residues of the
cI activator have been shown to contact the R588 and R596 residues of the
70 subunit of RNA polymerase. Similarly, the D241 residue of the E. coli RhaS protein, a member of the AraC/XylS family of transcriptional regulators, interacts with R599 of
70. Multiple activating regions that interact with both the
and
70 subunits of RNA polymerase also have been defined for the E. coli CRP activator; ARI (T158), ARII (H19, H21, D21, and K101) and ARIII (D53, E54, E55, and E58). It is notable that many of the residues shown to be involved in contacting RNA polymerase are charged, as is the case for D142 and R273.
Less is known about possible activating regions for LysR-type transcriptional regulators. Two studies propose that residues in the DNA-binding domain of these transcription factors contact the
subunit of RNA polymerase. L30A, F31A, and F32L substitutions in the E. coli GcvA regulator result in reduced activation of the gcvT promoter but do not reduce DNA binding or autorepression (6). Similarly, derivatives of the E. coli CysB protein with substitutions of the Y27, T28, and S29 residues are defective for activation of the cysP promoter but not for inducer or DNA binding (10). It is possible that LysR family members have multiple activating regions, as is the case for CRP. The GcvA protein has in fact been shown to interact with both
and
70 subunits of RNA polymerase (19).
The strongest support for the model that the D142 and R273 residues act as a contact point for RNA polymerase would come from the isolation of suppressor mutations in subunits of RNA polymerase, as has been the case for some of the non-LysR regulators described above. All genetic screens to isolate such suppressors for the putative OxyR positive control mutants thus far have been unsuccessful (data not shown), and no such suppressors have been reported for other LysR family members. Thus, additional biochemical and structural studies of LysR-type transcriptional regulators will need to be carried out before the precise contacts between this family of transcription factors and RNA polymerase can be defined.
This study was supported by the intramural program of the National Institute of Child Health and Human Development.
Published ahead of print on 29 September 2006. ![]()
Present address: Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892. ![]()
Present address: Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20852. ![]()
Present address: Department of Environmental Toxicology, University of California, Davis, CA 95616. ![]()
|| Present address: Department of Chemistry and Biochemistry, The University of South Carolina, Columbia, SC 29208. ![]()
|
|
|---|
as a target for transcription regulation. Mol. Microbiol. 48:863-874.[CrossRef][Medline]
and
subunits of RNA polymerase to activate the Escherichia coli gcvB gene and the gcvTHP operon. FEMS Microbiol. Lett. 242:333-338.[CrossRef][Medline]
subunit C-terminal region in co-operative interaction and transcriptional activation with OxyR protein. Mol. Microbiol. 7:859-864.[Medline]
subunit. J. Bacteriol. 177:6740-6744.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»